BACKGROUND: Pentavalent antimony, the generally accepted treatment for leishmaniasis, is given parenterally, and it is expensive and not readily available in developing countries. An inexpensive, orally administered compound would be a substantial advance in treatment. Previous studies in vitro have...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!